DK410787A - Oralt terapeutisk system med systemisk virkning - Google Patents

Oralt terapeutisk system med systemisk virkning

Info

Publication number
DK410787A
DK410787A DK410787A DK410787A DK410787A DK 410787 A DK410787 A DK 410787A DK 410787 A DK410787 A DK 410787A DK 410787 A DK410787 A DK 410787A DK 410787 A DK410787 A DK 410787A
Authority
DK
Denmark
Prior art keywords
therapeutic system
systemic effect
oral therapeutic
oral
systemic
Prior art date
Application number
DK410787A
Other languages
English (en)
Other versions
DK175497B1 (da
DK410787D0 (da
Inventor
Satish Chandra Khanna
Theresa Ruettimann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK410787D0 publication Critical patent/DK410787D0/da
Publication of DK410787A publication Critical patent/DK410787A/da
Application granted granted Critical
Publication of DK175497B1 publication Critical patent/DK175497B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK198704107A 1986-08-07 1987-08-06 Oralt terapeutisk system med systemisk virkning DK175497B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH317286 1986-08-07
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.

Publications (3)

Publication Number Publication Date
DK410787D0 DK410787D0 (da) 1987-08-06
DK410787A true DK410787A (da) 1988-02-08
DK175497B1 DK175497B1 (da) 2004-11-15

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198704107A DK175497B1 (da) 1986-08-07 1987-08-06 Oralt terapeutisk system med systemisk virkning

Country Status (30)

Country Link
US (1) US4857336A (da)
JP (1) JP2592460B2 (da)
KR (1) KR950006219B1 (da)
AT (1) AT397344B (da)
AU (1) AU597403B2 (da)
BE (1) BE1000235A3 (da)
CA (1) CA1302267C (da)
CH (1) CH668187A5 (da)
DD (1) DD285718A5 (da)
DE (1) DE3725824C2 (da)
DK (1) DK175497B1 (da)
ES (1) ES2007100A6 (da)
FI (1) FI86143C (da)
FR (1) FR2602425B1 (da)
GB (1) GB2193632B (da)
GR (1) GR871234B (da)
HK (1) HK33793A (da)
HU (1) HU206978B (da)
IE (1) IE59718B1 (da)
IL (1) IL83386A (da)
IT (1) IT1215618B (da)
LU (1) LU86966A1 (da)
MY (1) MY100767A (da)
NL (1) NL194780C (da)
NO (1) NO173726C (da)
NZ (1) NZ221347A (da)
PH (1) PH25090A (da)
PT (1) PT85489B (da)
SE (1) SE502590C2 (da)
ZA (1) ZA875804B (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2039287T3 (es) * 1987-01-14 1993-09-16 Ciba-Geigy Ag Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
FI933223A7 (fi) * 1991-01-16 1993-07-15 Fmc Corp Kantaja aktiivisia aineita varten ja sen avulla valmistettuja kiinteit ä annostusmuotoja
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
ATE195252T1 (de) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Wirkstoffabgabevorrichtung mit gesteuerter freigabe
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
CN1623533A (zh) 1997-09-25 2005-06-08 拜尔公司 控释活性化合物的药物制剂
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
DK1079813T3 (da) * 1998-04-29 2005-06-06 Virotex Corp Farmaceutisk bæreranordning, der er egnet til administration af farmaceutiske forbindelser til slimhindeoverflader
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
ATE508738T1 (de) * 2001-01-12 2011-05-15 Sun Pharma Advanced Res Co Ltd System zur beabstandeten abgabe von arzneimitteln
IN190699B (da) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
RU2324475C2 (ru) * 2001-04-10 2008-05-20 Сан Фармасьютикал Индастриз Лимитед Состав, выделяемый в импульсном режиме в заданное время
RU2189225C1 (ru) * 2001-09-14 2002-09-20 Нестерук Владимир Викторович Лекарственное средство на основе карбамазепина
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
WO2003075830A2 (en) * 2002-03-14 2003-09-18 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
RU2240798C1 (ru) * 2003-06-25 2004-11-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая противосудорожным и психотропным действием, и способ ее получения
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
JP2008539240A (ja) * 2005-04-25 2008-11-13 テバ ファーマシュ−ティカルズ ユーエスエー， インコーポレイテッド 持続放出性処方物
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
RU2504377C2 (ru) 2006-07-21 2014-01-20 БайоДеливери Сайенсиз Интэнэшнл, Инк. Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Also Published As

Publication number Publication date
MY100767A (en) 1991-02-14
DD285718A5 (de) 1991-01-03
IL83386A (en) 1992-01-15
BE1000235A3 (fr) 1988-09-20
KR950006219B1 (ko) 1995-06-12
DE3725824A1 (de) 1988-02-11
PH25090A (en) 1991-02-19
KR880002511A (ko) 1988-05-09
HU206978B (en) 1993-03-01
ZA875804B (en) 1988-02-08
GB2193632A (en) 1988-02-17
AT397344B (de) 1994-03-25
DK175497B1 (da) 2004-11-15
SE8703034D0 (sv) 1987-08-03
IL83386A0 (en) 1987-12-31
HUT44930A (en) 1988-05-30
FR2602425B1 (fr) 1990-09-14
NL194780C (nl) 2003-03-04
IT1215618B (it) 1990-02-22
SE8703034L (sv) 1988-02-08
AU7661787A (en) 1988-02-11
NO173726B (no) 1993-10-18
JP2592460B2 (ja) 1997-03-19
SE502590C2 (sv) 1995-11-20
PT85489B (pt) 1990-06-29
FI86143B (fi) 1992-04-15
HK33793A (en) 1993-04-16
DK410787D0 (da) 1987-08-06
CH668187A5 (de) 1988-12-15
NO173726C (no) 1994-01-26
NL194780B (nl) 2002-11-01
ATA199387A (de) 1993-08-15
FI873409A0 (fi) 1987-08-05
IE59718B1 (en) 1994-03-23
FI86143C (fi) 1992-07-27
PT85489A (en) 1987-09-01
NZ221347A (en) 1989-12-21
FI873409A7 (fi) 1988-02-08
NO873298D0 (no) 1987-08-06
DE3725824C2 (de) 1998-12-17
GR871234B (en) 1987-12-08
JPS6344525A (ja) 1988-02-25
CA1302267C (en) 1992-06-02
GB8717643D0 (en) 1987-09-03
US4857336A (en) 1989-08-15
ES2007100A6 (es) 1989-06-01
NL8701857A (nl) 1988-03-01
LU86966A1 (fr) 1989-03-08
IE872110L (en) 1988-02-07
AU597403B2 (en) 1990-05-31
IT8748270A0 (it) 1987-08-05
NO873298L (no) 1988-02-08
GB2193632B (en) 1990-04-25
FR2602425A1 (fr) 1988-02-12

Similar Documents

Publication Publication Date Title
DK410787D0 (da) Oralt terapeutisk system med systemisk virkning
DK16487D0 (da) Vacciner til oral indgift
FI872756L (fi) Med laserstraolning fungerande terapeutisk anordning.
DK153787D0 (da) Laegemidler med langsom frigivelse
PT89618A (pt) Sistema terapeutico oral flutuavel
DK100488A (da) Farmaceutisk plaster
DK326587A (da) Topisk farmaceutisk praeparat med systemisk virkning
FI88164C (fi) Metalljonskelat med en kelaterande dipyridoxalfosfatfoerening
DK62486D0 (da) Vaccine
DK62386D0 (da) Vaccine
AT384729B (de) Artikulator
DK201884D0 (da) Farmaceutisk praeparat med anti-hypertensiv virkning
FI864092A7 (fi) Bruksvagn foersedd med frigoerningsanordning
AT386333B (de) Artikulator
DK453785D0 (da) Laegemiddel med grf-virkning
DK692087D0 (da) Peptid med renin-inhibitorisk virkning
DK567786D0 (da) Ikke-adjuvansholdig vaccine
ATA88686A (de) Artikulator
ES289004Y (es) Almohada terapeutica perfeccionada
ES1006154Y (es) Almohada medicinal
ES287815Y (es) Dispositivo terapeutico anti-escoliosis
RO92692A2 (ro) Pansament medicinal
FI831109A0 (fi) Med vaogenergi fungerande pumpanordning
DK563886D0 (da) Terapeutisk komposition
DK544685D0 (da) Terapeutisk komposition

Legal Events

Date Code Title Description
PUP Patent expired